Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis
Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Emma M. Tillman
,
Cameron McKinzie
,
Dave Young
,
Charissa Kam
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Pediatric Pulmonology
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Description
DOI:
10.1002/ppul.71229
Similar Items
Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series
by: Charissa W. Kam, et al.
Published: (2024)
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
by: Cindy L. Williams, et al.
Published: (2025)
Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy
by: Cameron J. McKinzie, et al.
Published: (2024)
Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor
by: Richard De Vuyst, et al.
Published: (2024)
Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis
by: Rebecca S. Pettit, et al.
Published: (2024)